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Genetic differences that specify unique aspects of human evolution have typically been identified by 
comparative analyses between the genomes of humans and closely related primates1, including 
more recently the genomes of archaic hominins2,3. Not all regions of the genome, however, are 
equally amenable to such study. Recurrent copy number variation (CNV) at chromosome 16p11.2 
accounts for ~1% of autism cases4,5 and is mediated by a complex set of segmental duplications, 
many of which arose recently during human evolution. We reconstructed the evolutionary history 
of the locus and identified BOLA2 (bolA family member 2) as a gene duplicated exclusively in Homo 
sapiens. We estimate that a 95 kbp segment containing BOLA2 duplicated across the critical region 
~282 thousand years ago (kya), one of the latest among a series of genomic changes that 
dramatically restructured the locus during hominid evolution. All humans examined carry one or 
more copies of the duplication, which nearly fixed early in the human lineage—a pattern unlikely to 
have arisen so rapidly in the absence of selection (p < 0.0097). We show that the duplication of 
BOLA2 led to a novel, human-specific in-frame fusion transcript and that BOLA2 copy number 
correlates with both RNA expression (r = 0.36) and protein level (r = 0.65), with the greatest 
expression difference between human and chimpanzee in experimentally derived stem cells. 
Analyses of 152 patients carrying a chromosome 16p11.2 rearrangement showed that >96% of 
breakpoints occur within the Homo sapiens-specific duplication. In summary, the duplicative 
transposition of BOLA2 at the root of the Homo sapiens lineage ~282 kya simultaneously increased 
copy number of a gene associated with iron homeostasis and predisposed our species to recurrent 
rearrangements associated with disease. 
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 To reconstruct the evolutionary history of the chromosome 16p11.2 region, we generated 
complete, reference-quality genome sequence6 (Table S1) for one orangutan, two chimpanzee and three 
human haplotypes (Fig. 1a and Extended Data Fig. 1). Comparison with mouse establishes the 
orangutan configuration as ancestral. In both humans and chimpanzees, the region has been independently 
restructured, nearly doubling in length primarily by the differential accumulation of segmental 
duplications (Fig. 1a and Extended Data Fig. 1a). We find six inversions have occurred in the African 
great apes within chromosome 16p11.2 (Extended Data Figs. 2-4 and Tables S2, S3), a nonrandom 
clustering (p < 1 x 10-6), with breakpoints mapping near an ~20 kbp LCR16a (low copy repeat 16a) core 
duplicon. The core encodes a positively selected gene family (NPIP) that emerged on the human-African 
great ape lineage7. Only within the human lineage do large (>100 kbp) segmental duplications exist in a 
direct orientation flanking the autism critical region at breakpoint regions BP4 and BP5 (Extended Data 
Fig. 5a and Table S4)8, implying that susceptibility to large-scale CNV associated with disease4,5,9 arose 
specifically within the human species. 
Structural differences between human haplotypes are largely restricted to integral changes in the 
copy number of a 102 kbp block within both the proximal and distal breakpoint regions (Extended Data 
Fig. 1b). This block is composed of two different segmental duplications originating from chromosome 
16: a 72 kbp segment duplicated from chromosome 16p12.1 carrying NPIP and a portion of the SMG1 
serine-threonine kinase gene (SMG1P) and a 30 kbp segment carrying three intact genes: BOLA2, SLX1 
and SULT1A3 (Fig. 1a and Extended Data Fig. 1b). More than one dozen large-scale structural changes, 
including six duplicative transpositions (>830 kbp) from elsewhere on chromosome 16, are required to 
reconcile the organization of human and chimpanzee chromosome 16p11.2 (Extended Data Figs. 3, 4 
and Table S3). Assuming a human–chimpanzee divergence time of 6 million years ago (mya)10 and a 
constant substitution rate, we estimate that a 95 kbp segment including BOLA2 duplicated across the 
critical region ~282 kya (95% confidence interval: 361–209 kya), around the time when Homo sapiens 
emerged as a species11 (Fig. 1b, Fig. 2a, Extended Data Fig. 6, and Tables S5-S7). 
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We examined copy number diversity12 of the duplicated genes mapping to the 102 kbp cassette—
BOLA2, SLX1, and SULT1A3—in humans, archaic humans, and apes (Fig. 2b-c, Extended Data Fig. 7, 
and Tables S8-S10). We found that BOLA2 is duplicated in all Homo sapiens individuals examined, 
including archaic representatives of Neolithic and Mesolithic populations13, as well as the oldest 
sequenced archaic human, Ust’-Ishim, estimated to have lived 45 kya14. In sharp contrast, BOLA2 is 
single copy (i.e., diploid copy number = 2) in nonhuman primates and the archaic hominins Neanderthal2 
and Denisova3 (Fig. 2b-c and Table S8), consistent with our phylogenetic point estimate of the 
duplication age. Human genomes contain from 3 to 8 diploid BOLA2 copies, with at least one copy of the 
distal duplicate BOLA2B (range = 1–4; mean and median = 2 copies) and at least two copies of the 
proximal ancestral BOLA2A (range = 2–5 copies; mean and median = 4 copies, Fig. 2c and Table S8). 
In light of its recent origin and its potential to promote disease-causing rearrangement, we 
considered it remarkable that 99.8% of humans carry four or more copies of this segment. Ancient 
humans such as Ust’-Ishim as well as some of the oldest branches of modern humans (e.g., San and Biaka 
pygmy15) typically carry five or six copies, indicating that it spread rapidly early in human history. We 
modeled various evolutionary scenarios by simulation based on the observed genotypes and a realistic 
model of human demographic history (Extended Data Fig. 8a), assuming neutral evolution16-18. The 
observed genotypes or genotypes with higher BOLA2B frequencies only in humans were improbable (p < 
0.0097, Extended Data Fig. 8b), even when the duplication age parameter was varied by an order of 
magnitude. Scenarios incorporating recurrent duplication were also deemed unlikely (p < 0.0062). We 
next implemented a model incorporating the 282 kya age estimate but varying the selection coefficient (s) 
as an input parameter, yielding a maximum likelihood estimate of s = 0.0015 (Extended Data Fig. 8c). 
Interestingly, the unique ~550 kbp critical region flanked by BOLA2 duplications showed signatures 
consistent with a region under positive selection: the absence of archaic introgression19, low diversity 
(bottom 2.7%) and an excess of rare variants (Extended Data Fig. 8d-e). 
Because humans show extensive copy number variation, we assessed whether copy number 
correlated with mRNA and protein levels. We found a significant correlation between BOLA2 copy 
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number and expression at the RNA level based on analysis of 366 lymphoblastoid cell lines (LCLs)20 (r = 
0.36, p = 2.09 x 10-12, Fig. 3a and Tables S11, S12) and at the protein level based on analysis of whole-
protein lysates from 34 LCLs (r = 0.64, p = 4.34 x 10-5, Fig. 3b and Tables S13, S14). 
We also performed RT-PCR and identified an alternate gene structure composed of the first two 
exons from BOLA2 joined with three novel 3' exons from an older segmental duplication containing 
SMG1P (Fig. 3c). This fusion isoform contains an open reading frame (ORF) predicted to encode a 217 
residue protein including 53 residues from BOLA2 and 164 residues from SMG1P. Both canonical and 
fusion transcripts are co-expressed in a wide variety of tissues and developmental stages (Extended Data 
Fig. 9). Although the predicted fusion protein cannot be detected by existing antibodies, it is interesting 
that ribosome profiling data provide evidence that the mRNA is translated (Table S15). Importantly, 
since the ancestral BOLA2 at BP5 lacked the SMG1P duplication downstream, the origin of the fusion 
product must have coincided with the juxtaposition of BOLA2 and SMG1P by the tandem 102 kbp 
segmental duplication ~650–300 kya at BP5. We conclude that this fusion isoform is Homo sapiens-
specific. 
BOLA2 was previously identified as one of the top 50 genes differentially expressed between 
humans and nonhuman apes in induced pluripotent stem cells (iPSCs)21, implying that this gene might be 
particularly relevant early in development. Based on our characterization of the different BOLA2 
isoforms, we revisited this observation by quantifying BOLA2 mRNA levels by RNA-seq in human and 
chimpanzee iPSCs, iPSC-derived neural progenitor cells (NPCs), and eight-week-old neurons. 
Remarkably, we found the greatest differences in canonical BOLA2 expression at the iPSC state (2-fold) 
and to a lesser extent in NPCs (1.5-fold) (Fig. 3d and Table S16). Quantification of BOLA2 expression in 
two primary human embryonic stem cell (ESC) lines revealed transcript levels comparable to human 
iPSCs (Fig. 3d and Table S16). In contrast, examination of a panel of adult tissues22 revealed no 
substantial differences in BOLA2 mRNA levels between human and chimpanzee (Extended Data Fig. 
9d). As expected, expression of the fusion BOLA2-SMG1P transcript was detected exclusively in human. 
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The duplication of BOLA2 across the critical region expanded by threefold the size of flanking 
high-identity, directly oriented sequence blocks (Extended Data Fig. 5a-b and Tables S4, S17, S18), 
theoretically predisposing the locus to recurrent CNV via unequal crossover (Extended Data Fig. 5c) 
specifically in the human lineage. To test this, we refined breakpoint locations in autism and 
developmental delay patients carrying either the chromosome 16p11.2 microduplication or microdeletion 
event23. Using whole-genome sequence (WGS) data and a molecular inversion probe (MIP) assay24, we 
localized breakpoints in 152 patients corresponding to 105 independent rearrangement events (Fig. 4a, 
Extended Data Fig. 10, and Table S19). We found 96% (101 of 105) of the disease-causing 
rearrangement breakpoints map within the Homo sapiens-specific duplication containing BOLA2 (Fig. 
4b). Thus, the expansion of this segment rendered the chromosome 16p11.2 locus susceptible to recurrent 
rearrangement. 
In summary, the level of genetic difference between humans and chimpanzees for chromosome 
16p11.2 stands in sharp contrast to the oft-quoted 99% genetic identity between the species. The region 
has undergone extensive inversion and duplication, including a 95 kbp segment containing BOLA2 that 
duplicated after our divergence with ancient hominins. This event contributes more derived sequence 
specific to Homo sapiens than 35,500 previously reported human-specific single-nucleotide variants and 
indels combined2. The rapid rise and dispersal of this duplicated segment at the root of Homo sapiens 
(~282 kya) are unlikely to have occurred under neutral evolution but rather are consistent with modest 
positive selection (s = 0.0015). The estimated strength of selection on the BOLA2 duplication is an order 
of magnitude weaker than what is typically observed for recent positive selection (such as the emergence 
of lactase persistence ~10 kya25) but an order of magnitude stronger than nearly neutral mutations. 
Remarkably, the BOLA2 duplication rapidly rose to high frequency in humans despite predisposing our 
species to recurrent CNV associated with disease. The expansion of this segment resulted in the formation 
of a novel fusion transcript and dramatic BOLA2 expression differences between chimpanzee and human 
iPSCs. Although the phenotypic consequences of increased BOLA2 expression and the novel fusion 
transcript await future in vivo characterization, it is known that BOLA2 physically interacts in a 
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heterotrimeric complex with GLRX3 (glutaredoxin 3)26. This complex is conserved from prokaryotes to 
humans27 and was shown to have a role in iron sensing in yeast28. In vertebrates, BOLA2 has been 
hypothesized to play important roles in iron regulation29 and iron-sulfur protein biogenesis30. We 
speculate that the expansion of this conserved gene may enhance iron utilization and homeostasis, 
especially during human embryonic development. 
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Supplementary Information is linked to the online version of the paper at www.nature.com/nature. 
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LEGENDS 
 
Figure 1. Comparative sequence analysis of chromosome 16p11.2 among apes and the evolution of 
BOLA2 duplications in humans. a) Schematic depicts the genomic organization of chromosome 
16p11.2 for one orangutan and one chimpanzee haplotype along with the human reference haplotype 
(GRCh37 chr16:28195661-30573128). Blocks of segmental duplications within this locus mediate 
recurrent rearrangements in humans and have thus been defined as breakpoint regions BP1-BP5 (ref. 8). 
Colored boxes and thick arrows indicate the extent and orientation of segmental duplications (different 
colors denote duplicons from different ancestral genomic loci, and hashed boxes indicate sequence 
duplicated in humans but not in the species represented). Thin numbered arrows show orientations of 
gene-rich regions of unique sequence. Red triangles indicate locations and orientations of NPIP cores. 
Numbers (left) indicate the size of each haplotype, with the number of segmentally duplicated base pairs 
shown in parentheses. For chimpanzee, the size is a lower bound due to gaps (dotted line sections) and the 
contig not reaching unique region 1. Regions of human copy number variation (yellow highlight) occur 
on both sides of the critical region and involve the same 102 kbp unit: a 30 kbp block (green arrow) 
containing BOLA2, SLX1, and SULT1A3 and a 72 kbp block (orange arrow) harboring SMG1P. 
Expansion and contraction of this cassette underlie hundreds of kbp of structural diversity between human 
haplotypes. b) A model for the emergence of BOLA2 duplications during Homo sapiens evolution. 
Schematic depicts structural changes over time leading to the present-day human architecture. A full 
evolutionary model detailing the dynamic evolution of chromosome 16p11.2 in great apes is provided in 
the Supplementary Information and Extended Data Figs. 3, 4. 
 
Figure 2. Homo sapiens-specific BOLA2 duplication and copy number diversity. a) A phylogenetic 
tree representing the last interspersed segmental duplication from BP5 to BP4 in humans. The unrooted 
neighbor-joining tree was constructed from a 21,102 bp multiple sequence alignment including allelic, 
paralogous, and orthologous copies of the BOLA2-containing segmental duplications. Human taxon labels 
denote haplotypes and locations of different copies (telomeric, T, blue; centromeric, C, red, with C1 
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closer to the critical region than C2). The number of substitutions (above each branch) and bootstrap 
support (at nodes) are indicated. Timing estimates assume human-chimpanzee divergence 6 mya10. b) 
Diploid copy number estimates (points) for BOLA2 based on sequence read depth12 are shown for 2,359 
humans, three archaic humans13,14, a Neanderthal2, a Denisovan3, and 86 nonhuman primates, with violin 
plots overlaid. c) Paralog-specific BOLA2 copy number genotypes (points, jittered around their integer 
values) were inferred from WGS read depth over informative markers for 222 individuals sequenced to 
high coverage. Colors correspond to different populations as in panel b. 
 
Figure 3. BOLA2 expression analyses. a) Normalized BOLA2 mRNA expression quantifications20 in 
366 LCLs from individuals genotyped for BOLA2 paralog-specific copy number. Points indicate 
expression levels and copy number (jittered) for each cell line, and horizontal lines show the mean 
expression level for each copy number. Line shows least squares regression. Point colors indicate 
BOLA2B copy number (pink = 1 copy, black = 2 copies, cyan = 3 copies). Groups with the same 
aggregate BOLA2 copy number but different combinations of paralog-specific copy number do not 
exhibit differential expression, consistent with both BOLA2A and BOLA2B producing mRNA. b) Plot 
layout is the same as in panel a, but data show BOLA2 protein expression quantified by Western blot 
densitometry on protein lysates from 34 LCLs. Though the sample size is small, no evidence indicates 
differential protein expression of distinct BOLA2 paralogs. c) BOLA2 gene models, predicted protein 
products, and support from RNA-seq data from human iPSCs. RT-PCR, cloning, and capillary 
sequencing experiments identified three BOLA2 isoforms: the canonical isoform (BOLA2, black) 
encoding an 86 residue protein and two fusion isoforms consisting of the first two exons from canonical 
BOLA2 fused with three exons from SMG1P. One of the fusion isoforms (BOLA2F, blue) maintains the 
BOLA2 ORF well beyond the fusion junction and is predicted to encode a 217 residue protein deriving 
primarily from SMG1P, whereas a third isoform (BOLA2T, red) contains a premature stop codon within 
the first SMG1P-derived exon. Numbers next to curved lines indicate mean counts of RNA-seq reads 
from two human iPSCs (two independent clones each) supporting each exon-exon junction, with standard 
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errors in parentheses. d) RNA-seq quantification of BOLA2 mRNA expression through in vitro 
differentiation of primate iPSCs into neurons. Data from two human and two chimpanzee cell lines (two 
independent clones each, except for neurons) reveal significantly higher levels of BOLA2 transcripts in 
human iPSCs than in chimpanzee iPSCs and that BOLA2 RNA levels decrease through neuronal 
differentiation. Bar heights indicate mean expression levels for each species and differentiation stage in 
transcripts per million (TPM), with error bars showing standard errors. Bar colors correspond to different 
BOLA2 isoforms as in panel c. BOLA2 expression in human ESCs (two cell lines) is consistent with data 
from human iPSCs, suggesting the iPSC data accurately reflect BOLA2 expression at early stages in 
development. 
 
Figure 4. Refinement of chromosome 16p11.2 rearrangement breakpoints. a) Results of whole-
genome sequencing of a family with a de novo chromosome 16p11.2 microdeletion in a child with 
autism. Normalized read depth at unique 30-mer positions in the human reference genome GRCh37 is 
depicted for the proband, her mother, and her father. Read-depth signatures reveal a deletion in the 
proband extending between but not beyond the Homo sapiens-specific duplicated sequences (highlighted 
in pink). b) Summary of results across 105 independent microdeletion and microduplication events from 
152 individuals. ~96% of breakpoints map to the Homo sapiens-specific segmental duplication. 
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METHODS1-30 
Single-molecule, real-time (SMRT) sequencing was used to generate high-quality sequence6 from 
bacterial artificial chromosome (BAC) clones obtained from genomic libraries. Clone sequences were 
assembled using HGAP and error-corrected using Quiver31. Contig assembly was performed using 
Sequencher (Gene Codes Corporation, Ann Arbor, MI) and validated by FISH. Copy number genotyping 
of genes and segmental duplications was performed using a read-depth method12 and WGS data from 
humans32,33, nonhuman primates34, and archaic genomes2,3,13,14, as well as single molecule MIPs 
(smMIPs)35 targeted to paralogous sequence variants24. We estimated evolutionary timing of segmental 
duplication events based on comparative sequencing and phylogenetic analyses (neighbor-joining 
method), adjusting branch lengths for trees that failed the Tajima’s relative rate test and assuming 
divergence times of 6 mya (human–chimpanzee)10 and 15 mya (human–orangutan). Evolutionary 
conservation analysis of BOLA2 was performed by maximum likelihood (PAML). Likelihoods of 
BOLA2B fixation under different scenarios were assessed using the coalescent simulators ms17 and 
msms18, adapting a previously published demographic model16. BOLA2 copy number estimates were 
correlated (Pearson’s r) using RNA-seq quantifications20 (PEER-normalized RPKM) and Western blot 
BOLA2 densities in human LCLs grown in complete RPMI medium and lysed in RIPA buffer. After 
SDS-PAGE and transfer to PVDF membrane, blots were incubated with an anti-BOLA2 antibody (Santa 
Cruz Biotechnology, Dallas, TX) and an anti-actin antibody (Sigma) for normalization purposes. Band 
densities were quantified using the Bio1D software. BOLA2 coding DNA sequence (CDS) was cloned 
using the Gateway system (Invitrogen, Carlsbad, CA). HeLa cells were transfected with cytomegalovirus-
BOLA2 CDS (both 10 and 17 kDa forms) and analyzed by Western blotting. BOLA2 gene models were 
established via RT-PCR, cloning, and capillary sequencing. RNA-seq data were generated from 
previously described ESC and iPSC lines21, as well as iPSC lines differentiated into NPCs and neurons. 
BOLA2 mRNA expression was quantified in transcripts per million (TPM) with Kallisto36 (version 
0.42.1) using a custom catalog of transcripts including all human RefSeq transcripts with the three 
BOLA2 isoforms. Breakpoints of chromosome 16p11.2 rearrangements were refined using Illumina 
whole-genome shotgun sequencing37,38 and smMIP analysis24,35,37 of patient DNA obtained from the 
Simons Variation in Individuals Project (Simons VIP)23 and Simons Simplex Collection (SSC)39. All 
procedures for clinical assessment and blood extraction were approved by the institutional review boards 
(IRBs) of participating institutions, and informed consent was obtained for participation in this research. 
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EXTENDED DATA LEGENDS 
Extended Data Figure 1. Comparative sequence analysis of chromosome 16p11.2 among apes. a) 
Schematic depicts the genomic organization of chromosome 16p11.2 for one orangutan and two 
chimpanzee haplotypes along with the human reference haplotype (GRCh37 chr16:28195661-30573128; 
see ideogram for approximate chromosomal location). Blocks of segmental duplications within this locus 
mediate recurrent rearrangements in humans; thus, these blocks have been defined as breakpoint regions 
BP1-BP5 (ref. 8). The ~550 kbp critical region (pink) and a >1 Mbp chimpanzee-specific inversion 
polymorphism (orange) are highlighted. Tiling paths of sequenced clones are indicated above each 
haplotype, with chimpanzee clones that could not be fully resolved marked with asterisks. Colored boxes 
and thick arrows indicate the extent and orientation of segmental duplications (with different colors 
denoting duplicons from different ancestral genomic loci, and hashed boxes indicating sequence 
duplicated in humans but not in the species represented). Thin numbered arrows show orientations of 
gene-rich regions of unique sequence. Numbers (left) indicate the size of each orthologous haplotype, 
with the number of segmentally duplicated base pairs shown in parentheses. Note that, for chimpanzee, 
these sizes are lower bounds due to gaps in the contigs (dotted line sections) and the contigs not reaching 
unique sequence beyond BP1 (i.e., unique region 1). b) Schematic depicts distinct human structural 
haplotypes over the chromosome 16p11.2 critical region and flanking sequences (three complete 
haplotypes extending from unique sequence distal to BP3 to unique sequence proximal to BP5 and one 
partial haplotype including BP3-BP4 and BP5 sequence contigs). High-quality sequence for each 
haplotype was generated by sequencing a total of 40 BACs and 15 fosmids from three different human 
genomic libraries. Regions of copy number variation (highlighted in yellow along the first two 
haplotypes) occur on both sides of the critical region and involve the same 102 kbp unit in direct 
orientation, including a 30 kbp block containing BOLA2 and two other genes and a 72 kbp block 
harboring a partial segmental duplication of SMG1 (SMG1P). Expansion and contraction of this cassette 
underlie hundreds of kbp of structural diversity between human haplotypes. BOLA2 paralog-specific copy 
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number genotype data suggest that H1 and H3 likely represent the most common haplotype structures in 
humans. 
 
Extended Data Figure 2. Comparison of chromosome 16p11.2 structure between apes. a) Sequences 
(thin horizontal lines) from human (GRCh37 chr16:28195661-30573128) and orangutan (contig 
sequence) at chromosome 16p11.2 are compared using Miropeats (s = 1,000) and annotated with 
locations of human segmental duplications and FISH probes used to validate the organization of the 
region. Lines connecting the sequences show regions of homology, and line colors highlight differences 
in the order and orientation of distinct gene-rich regions of unique sequence across the locus (numbered 
1-6). Numbers below FISH probes correspond to numbers within the images on the right, specifying 
which probes were used in each experiment. Experiment 1 used the same probes as experiment 3, and 
experiment 2 used the same probes as experiment 4. Three-color interphase FISH on human and 
orangutan chromosomes confirms the accuracy of our assembled orangutan contig. b) Sequences (thin 
horizontal lines) from human (GRCh37 chr16:28195661-30573128) and two chimpanzee structural 
haplotypes at chromosome 16p11.2 are compared using Miropeats (s = 1,500) and annotated with 
locations of human segmental duplications and FISH probes used to validate the organization of the 
region. Thick red horizontal lines indicate gaps in the chimpanzee contigs, and black boxes correspond to 
chimpanzee-specific segmental duplications (i.e., sequences not duplicated in humans). Lines connecting 
the sequences show regions of homology, and line colors highlight differences in the order and 
orientation of distinct gene-rich regions of unique sequence across the locus (numbered 2-6). Numbers 
below FISH probes correspond to numbers within the images on the right, specifying which probes were 
used in each experiment. Gray rectangles show mapping locations of FISH probes in human. Three-color 
interphase FISH on chimpanzee chromosomes confirms the accuracy of our assembled contigs. 
 
Extended Data Figure 3. Dynamic evolution of human chromosome 16p11.2. a) A model for the 
evolution of the chromosome 16p11.2 BP1-BP5 region (ref. 8) during great ape evolution. The schematic 
depicts structural changes over time leading to the present-day human architecture (see Supplementary 
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Information for details). The orangutan structure (top) is largely devoid of segmental duplications and 
deemed to represent the ape ancestral organization because it is conserved with mouse. Subsequent steps 
were inferred based on phylogenetic reconstruction, origins of the duplicated sequences, and the most 
parsimonious path with respect to changes in gene order (inversions). (See Supplementary Information 
for a detailed discussion of all supporting evidence and confidence levels for each step.) Note that, 
without access to genomes containing intermediate chromosome 16p11.2 structures, it is impossible to 
know with certainty the entire step-by-step evolutionary history. Some details presented here may not be 
accurate. 
 
Extended Data Figure 4. Dynamic evolution of chimpanzee chromosome 16p11.2. A model for the 
evolution of the chromosome 16p11.2 BP1-BP5 region (ref. 8) during great ape evolution. The schematic 
depicts structural changes over time leading to the present-day chimpanzee architecture (see 
Supplementary Information for details and discussion of all supporting evidence and confidence levels 
for each step.). 
 
Extended Data Figure 5. Comparison of duplications around the chromosome 16p11.2 autism 
critical region among apes and NAHR model underlying CNV at human chromosome 16p11.2. a) 
Local directly oriented (green) and inversely oriented (blue) intrachromosomal segmental duplications 
flanking the chromosome 16p11.2 autism critical region (purple) are visualized using Miropeats (s = 
1,000). Gaps in the chimpanzee C1 contig are shown in red. The smaller size (<50 kbp) and lower 
average sequence identity (at most 98.6%) of directly oriented duplications flanking the critical region in 
chimpanzee compared to human haplotypes including BOLA2 on both sides of the critical region (at least 
147 kbp of directly oriented duplications having at least 99.3% average sequence identity) suggest that 
susceptibility to NAHR resulting in microdeletions and microduplications at this locus evolved 
specifically in humans. b) Perfect sequence identity tract lengths (>500 bp) within directly oriented 
duplications flanking the critical region for human vs. chimpanzee. Histograms show counts of tracts of 
perfect sequence identity (lacking single-nucleotide variants and indels) between directly oriented 
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segmental duplications of interest within each indicated haplotype and the distribution of these tracts over 
different size ranges. Human haplotypes having BOLA2 on both sides of the critical region (bottom 
panels) contain the highest number of such tracts and the longest such tracts, including one tract spanning 
10,774 bp. In contrast, the longest tract of perfect sequence identity between duplications of interest in 
chimpanzee (considering both the C1 and C2 haplotypes) spans 450 bp. c) NAHR model underlying 
normal and disease-associated CNV at human chromosome 16p11.2. 
 
Extended Data Figure 6. Sequence refinement of interspersed BOLA2 duplication breakpoints, 
inference of BOLA2 duplication mechanism, and phylogenetic BOLA2 duplication timing. a) H1 
human BP4 sequence (orange, green, orange, and blue arrows in inset) was aligned to its allelic (black 
arrows in inset) and paralogous (red arrows in inset) counterparts. The sequence identity for each 
alignment was computed and plotted over 2 kbp windows, sliding by 100 bp. Black lines indicate 
sequence identity for allelic comparisons, whereas red lines correspond to paralogous comparisons. While 
the allelic comparisons exhibit uniform, near-perfect sequence identity across the entirety of the 
alignment, paralogous comparisons reveal three distinct levels of sequence identity, with the highest level 
in the middle. This pattern suggests that the BOLA2 duplication (highest-identity region, 95 kbp) landed 
within an evolutionarily older segmental duplication having paralogs at BP4 and BP5. Dashed vertical 
lines (numbered i-iv) indicate putative breakpoints for events that occurred after this older segmental 
duplication. Junction sequence from the BP5 102 kbp tandem duplication (i.e., the SMG1P-BOLA2 
junction) was clearly included in the 95 kbp duplication from BP5 to BP4. b) Alignment of BP4 
sequences containing the putative left (red arrows in inset) and right (dark blue arrows in inset) BOLA2 
duplication breakpoints to the BP5 paralog associated with the evolutionarily older segmental duplication 
(orange and light blue arrows in inset) and sliding window sequence identity analysis supports the 
hypothesis outlined above. Sequence identity lines for comparisons involving left and right BP4 
sequences intersect in the vicinity of the hypothesized BOLA2 duplication breakpoints. Comparing this 
result with the same analysis of the human H2 BP4 sequence lacking BOLA2 (green arrows in inset and 
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green identity line) suggests this BP4 sequence represents the ancestral state of BP4 before the BOLA2 
duplication arrived. Thus, two levels of sequence identity existed between BP4 and BP5 before the 
BOLA2 duplication, consistent with an interlocus gene conversion event. c) Alignment of BP4 sequences 
(orange arrows in insets) containing the putative BOLA2 duplication breakpoints to their ancestral BP4 
(top plot) and their ancestral BP5 (middle plot) counterparts and sliding window sequence identity 
analysis reveals an ~7 kbp window (highlighted in orange) defining the BOLA2 duplication breakpoints. 
Analysis of the underlying multiple sequence alignment (Table S5) identified positions with signatures 
informative for breakpoint localization (blue vertical lines, left BP4 72 kbp block outside of the BOLA2 
duplication and right BP4 72 kbp block within the BOLA2 duplication; yellow vertical lines, left BP4 72 
kbp block within the BOLA2 duplication and right BP4 72 kbp block outside of the BOLA2 duplication). 
Gray vertical lines indicate positions showing signatures of interlocus gene conversion. As both left and 
right 72 kbp block BP4 sequences within the ~7 kbp window are more highly identical to ancestral BP4 
sequence (20/24 informative positions match the ancestral BP4 sequence) than to ancestral BP5 sequence, 
it is likely that this interval was involved in the BOLA2 duplication but duplicated only within BP4. Its 
boundaries define the most likely BOLA2 duplication breakpoints, and this pattern of sequence identity 
suggests a template switching replicative mechanism as most likely underlying the BOLA2 duplication 
event. d) Template-switching model for the formation of BOLA2B. This mechanism was inferred from the 
sequence identity analyses in panels a-c and from analysis of a multiple sequence alignment (Table S5). 
e) Phylogenetic characterization of the 95 kbp duplication containing BOLA2 from BP5 to BP4. 
Cladogram representation of an unrooted neighbor-joining phylogenetic tree based on a 21,102 bp 
multiple sequence alignment spanning BOLA2 and most of the 30 kbp block including human sequences 
from BP4 and BP5 and single-copy orthologous sequences from chimpanzee, gorilla, and orangutan. 
Branch lengths (substitutions per site) are shown on each branch (black decimal numbers), and bootstrap 
support is indicated (black integers at nodes). Blue numbers correspond to nodes and indicate average 
branch lengths for all sequences in corresponding clades. Branch lengths were used to estimate the time 
corresponding to the 95 kbp duplication containing BOLA2 from BP5 to BP4 as shown. 
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Extended Data Figure 7. Analyses of BOLA2 aggregate and paralog-specific copy number variation 
in humans. a) Interphase FISH confirms both BOLA2A and BOLA2B show copy number variation. 
Previous interphase FISH analysis (data not shown) suggests the individual NA20127 has six total copies 
of BOLA2. Diagram outlines a three-color FISH assay including two probes (blue, green) targeting 
sequences within the autism critical region and one probe (red) targeting ~18 kbp of sequence (including 
BOLA2) over the 30 kbp duplication block. Signals from the red probe are detected on the telomeric 
(BP4) and centromeric (BP5) sides of the critical region (adjacent to the blue and green probes, 
respectively) on both chromosome 16 homologs. However, the red probe signal intensity is strongest 
adjacent to the green probe for one homolog but, in contrast, is strongest adjacent to the blue probe for the 
other chromosome 16 homolog, consistent with higher BOLA2A copy number in the first case and higher 
BOLA2B copy number in the second case. These data indicate that individual NA20127 has three copies 
each of BOLA2A and BOLA2B. This differential signal intensity pattern does not result from an inversion 
of the chromosome 16p11.2 critical region in this individual, as data from another FISH experiment (data 
not shown) refute this possibility. Information on probes used in these FISH experiments is provided in 
Table S2. b) Interphase FISH experiments using a probe targeting BOLA2 and surrounding sequence for 
individuals having the lowest (3) and highest (8) confirmed aggregate BOLA2 copy numbers. c) Left and 
middle schematics detail three distinct sectors of the 72 kbp blocks (orange arrows). Each block has 
paralogous sequence variants that are informative for particular region(s) when compared to others in 
chromosome 16p11.2. These markers are color-coded into three sectors within the 72 kbp block of 
paralogy (a 59 kbp sector, blue and red boxes; a 7 kbp sector, green and orange boxes; and a 6 kbp sector, 
purple and yellow boxes), indicating which particular regions they distinguish. Right schematic shows 
known haplotype structures for individual NA12878. d) Analyzing WGS data from NA12878 yields copy 
number estimates for BOLA2A and BOLA2B that match the known BOLA2 PSCN for this individual. 
Each point shows a relative marker-specific read count frequency (y-axis) and its position within the 
duplication blocks (x-axis). Point colors correspond to different marker sets for each sector, as diagramed 
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in panel c. Fractions indicate the relative copy number of each marker set. Estimates of 4/6 (red marker 
set) vs. 2/6 (blue marker set) for the 59 kbp sector confirms the sequenced architecture (panel c) with an 
aggregate of 4 BOLA2 copies, and the estimate of 3/6 (orange marker set) confirms three copies of 
BOLA2A. WGS analysis also yields accurate PSCN estimates for the 45 kbp block. e) Using MIPs, we 
employed the same relative read-depth strategy. Genotyping results for the same sample as in panel d are 
shown, with additional markers (points not color-coded as in panels c-d) added based on polymorphic 
variants (symbols indicate different patterns of presence/absence among 72 kbp blocks, considering all 
such blocks from our four contiguous human haplotypes). MIP genotypes confirm WGS estimates (in 
panel d). f) BOLA2 PSCN genotypes (points, jittered around their integer values for clarity) were inferred 
from MIP sequence data for 894 humans. Numbers indicate total counts of individuals in each population 
having a particular BOLA2 PSCN genotype. Low-confidence estimates were excluded. 
 
Extended Data Figure 8. Population genetic modeling of the BOLA2B duplication and critical 
region analyses. a) Demographic model (adapted from ref. 16) used to simulate BOLA2B evolution under 
different scenarios. NANC, effective population size of Homo ancestor, 21,600. NARC, effective population 
size of Neanderthal-Denisova ancestor, 500. NHUM, effective population size of human ancestor, 24,000. 
NYRE, effective size of Yoruban population after expansion, 45,000. NDEN, effective population size of 
Denisova, 500. NNEA, effective population size of Neanderthal, 500. NYRI, effective size of extant Yoruban 
population, 10,000. NSAN, effective size of extant San population, 10,000. T1, time of archaic hominin 
divergence from modern humans, 650,000 years. T2, time of Neanderthal-Denisova divergence, 525,000 
years. Tdup, time of formation of BOLA2B, 282,000 years. T3, time of Yoruban-San divergence, 200,000 
years. T4, time of Yoruban population expansion, 157,500 years. T5, time of Yoruban population decline, 
37,500 years. b) Simulation results (n = 1,000,000) assuming that the duplication that formed BOLA2B 
occurred once, 282 kya, along the modern human ancestral lineage and evolved under neutrality 
compared to the observed genotype frequencies of BOLA2B in 8 San and 110 Yoruban haplotypes. Nearly 
all (999,531) simulations resulted in BOLA2B being lost from both populations; results from the 
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remaining 469 simulations (black) are shown alongside the observed data (red, circled). Under this simple 
neutral model incorporating BOLA2B age, the observed BOLA2B frequency is never approached. c) 
Simulation was repeated exploring a range of selection coefficients from 0.0009 to 0.0024 (increments of 
0.0001), and the relative probability of the observed data under each scenario was calculated as the 
proportion of simulations yielding the observed BOLA2B genotypes among simulations where BOLA2B 
was not lost relative to the maximum such proportion for any single selection coefficient considered. The 
maximum likelihood estimate for the selection coefficient was s = 0.0015. Smoothed line is LOESS 
regression curve. d) Low average heterozygosity of the chromosome 16p11.2 BP4-BP5 critical region. 
Distribution of average heterozygosity values for 100,000 ~550 kbp regions of unique sequence randomly 
sampled with replacement from the autosomal genome compared to average heterozygosity values for the 
critical region (black line) and flanking unique sequences (colored lines). The critical region lies in the 
bottom 2.6% of the distribution, showing low diversity consistent with potential positive selection. 
Bottom schematic indicates locations of the critical region and flanking unique regions in relation to 
segmental duplications across the locus—note that BOLA2A is located at BP5 and BOLA2B at BP4. e) 
Low Tajima’s D score for the chromosome 16p11.2 BP4-BP5 critical region. Distribution of Tajima’s D 
scores for 2,987 non-overlapping ~550 kbp regions across the genome compared to Tajima’s D scores for 
the critical region (black line) and flanking unique sequences (colored lines). The critical region lies in the 
bottom 2.7% of the distribution, consistent with possible positive selection. The distribution is centered 
near -2 rather than 0 because most SNVs in the 1000 Genomes dataset are rare variants having arisen 
during the large expansions of human populations over the past 100,000 years. Bottom schematic 
indicates locations of the critical region and flanking unique regions in relation to segmental duplications 
across the locus. 
 
Extended Data Figure 9. BOLA2 expression and antibody validation. a) RT-PCR expression profile 
for canonical BOLA2. The expected product size for canonical BOLA2 (838 bp) was observed in all eight 
human tissues. 1 kb + DNA ladder (Thermo Fisher). b) RT-PCR expression profile for BOLA2-SMG1 
21	
	
fusion product. The expected product size for the BOLA2 fusion transcript (1,239 bp) was observed as a 
doublet in all tissues except skeletal muscle. Intensity of upper band differs between tissues. 1 kb + DNA 
ladder (Thermo Fisher). c) BOLA2 RNA-seq expression analysis. Canonical (BOLA2) and fusion 
transcripts (BOLA2F, BOLA2T) were assessed across 25 humans from GTEx RNA-seq data. Bar heights 
indicate mean expression levels for each tissue in TPM with standard errors shown (error bars). Colors 
correspond to different BOLA2 isoforms as indicated. d) BOLA2 expression among primates in six adult 
tissues. Each point indicates a BOLA2 expression estimate from a single tissue sample, with samples 
obtained from a total of 18 humans, 6 chimpanzees, and 3 bonobos. Open circles correspond to 
individuals analyzed in a single experiment, while closed shapes denote data from multiple experiments 
involving the same individual, with each distinct color + shape pattern showing all experiments for a 
particular individual. Horizontal lines show mean expression values for each species and tissue. 
Combined with our expression analyses of iPSCs, these data show BOLA2 expression differs substantially 
between human, chimpanzee, and bonobo only in stem cells. e) Western blotting of HeLa cells transfected 
with the human BOLA2 annotated CDS and probed with an anti-BOLA2 antibody (Sc-163747). Whole-
cell lysate of HeLa cells non-transfected with the overexpression construct (lane 1) and transfected with 
the human BOLA2 annotated CDS (lane 2) were probed with anti-BOLA2 antibody. Two bands with 
molecular weights of 10 and 17 kDa are identified and more abundant in transfected cells and correspond 
to two BOLA2 protein isoforms arising from different translation start sites. 
 
Extended Data Figure 10. Chromosome 16p11.2 rearrangement breakpoint refinement. a) 
Schematic depicts NAHR between directly oriented segmental duplications at BP4 and BP5. This unequal 
crossover results in chromosome 16p11.2 microdeletions and microduplications (Extended Data Fig. 
5c). Colored arrows and boxes correspond to duplication blocks and sectors within them color-coded as in 
Extended Data Fig. 7c. Unequal crossover could occur in eight distinct regions with regard to 
duplication block and sector boundaries. Three such regions are located within the ~95 kbp Homo 
sapiens-specific duplication (dashed lines). Only unequal crossover events outside the Homo sapiens-
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specific duplication produce recombinants having a sector with non-uniform marker-specific copy 
number across its extent. b) Plot shows relative marker-specific read count frequencies (points) 
determined from WGS analysis for a microdeletion proband. Fractions indicate relative marker-specific 
copy numbers, as in Extended Data Fig. 7d, and diagrams adjacent to the plot show inferred haplotype 
structures for each chromosome 16 homolog for this individual. Though the data in the plot provide only 
diploid genotypes (and not resolved haplotypes), the haplotypes suggested here reflect this genotype 
information together with data from the parents (not shown) and the assumption (supported by our PSCN 
data) that haplotypes having two BOLA2A copies and a single BOLA2B copy are the most common. 
Because marker-specific copy number is uniform across each sector, unequal crossover breakpoints must 
have occurred within the Homo sapiens-specific duplication. c) Breakpoint refinement based on MIP 
PSCN marker data. Plots show relative marker-specific read count frequencies (points) determined using 
MIPs for a typical microdeletion patient (left) and a typical microduplication patient (right). Shapes and 
color code designate different markers, and fractions indicate relative marker-specific copy numbers (as 
in Extended Data Fig. 7). Because marker-specific copy number is uniform across each sector for both 
individuals, in both cases, unequal crossover breakpoints must have occurred within the Homo sapiens-
specific duplication. d) Data from an atypical patient where the breakpoints are inferred to map outside of 
the Homo sapiens-specific segmental duplication. The plots show paralog-specific copy number for a 
chromosome 16p11.2 microdeletion proband, his sibling, and his mother over a 45 kbp duplication block 
shared between BP4 and BP5. Paralog-specific copy number was estimated using a MIP assay targeting 
54 informative markers over this region, with data from 43 markers fixed among haplotypes H1-H4 
shown (points). Dashed lines indicate calls inferred using an automated caller, which were also confirmed 
by visual inspection. Adjacent schematics indicate the inferred haplotypes for each individual based on 
these data, with approximate breakpoint locations shown (arrows). The results demarcate the location of 
the unequal crossover interval based on the reciprocal copy number transition between the BP5 (red) and 
BP4 (blue) 45 kbp block segmental duplications. In this case, the breakpoints clearly map to a 22 kbp 
region outside of the typical hotspot. Analysis of the sibling suggests that this region was the site of an 
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interlocus gene conversion event from BP5 to BP4, and data from the mother imply that chromosomes 
having this event were present in the paternal germline. DNA from the father was not available for 
testing. 
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